Can heart failure lead to device therapy? 

Heart failure is a chronic condition where the heart muscle becomes too weak or stiff to pump blood effectively around the body. In the UK, while medication remains the first line of treatment, many patients eventually require device therapy to manage symptoms and reduce the risk of sudden cardiac arrest. These sophisticated implants are designed to either coordinate the heart’s contractions or provide a safety net against lethal heart rhythms. 

In this article, you will learn about the specific devices used in heart failure management, such as Cardiac Resynchronisation Therapy (CRT) and Implantable Cardioverter Defibrillators (ICDs). We will also discuss the clinical criteria for implantation, the underlying causes of heart failure that necessitate these devices, and the triggers that may signal a need for advanced intervention. 

What We’ll Discuss in This Article 

• How heart failure affects the heart’s electrical and mechanical function 

• The role of Cardiac Resynchronisation Therapy (CRT) in improving pump efficiency 

• Why an ICD is used as a safety net in patients with a low ejection fraction 

• Clinical indications for devices based on NICE guidelines 

• Common causes of heart failure that lead to device therapy 

• Triggers that suggest medication alone is no longer sufficient 

• Essential safety and emergency guidance for heart failure patients 

Why heart failure necessitates device therapy 

Heart failure can lead to a condition called dyssynchrony, where the left and right sides of the heart do not beat in time with each other. This makes the heart an even less efficient pump. Furthermore, the structural changes and scarring associated with heart failure can disrupt the heart’s electrical system, putting the patient at high risk of fast, life threatening arrhythmias. Device therapy is used to address these specific electrical and mechanical failures. 

In the UK, the most common measure used to determine if a device is needed is the ejection fraction (EF), which is calculated via an echocardiogram. If the EF is significantly low, usually below 35 percent, the risk of sudden cardiac arrest increases. Devices like the ICD or CRT D are implanted to monitor the heart 24 hours a day and intervene if the rhythm becomes dangerous or if the pumping action becomes too inefficient. 

• Cardiac Resynchronisation Therapy (CRT): A pacemaker that uses three leads to coordinate the chambers of the heart. 

• Implantable Cardioverter Defibrillator (ICD): A device that delivers a shock to stop life threatening fast rhythms. 

• Low Ejection Fraction: A key clinical indicator that the heart is not pumping enough blood. 

• Dyssynchrony: When the walls of the heart muscle contract at different times. 

Specific devices for heart failure management 

There are two primary types of device therapy for heart failure. The first is CRT, often called a biventricular pacemaker. This device helps the heart beat more effectively by sending small electrical impulses to both the left and right ventricles simultaneously. This resynchronisation can significantly improve symptoms like breathlessness and fatigue, allowing patients to be more active. 

The second is the ICD. While many heart failure patients receive a combined device (CRT D), some may only require the ICD function. This device does not necessarily help the heart pump better day to day, but it acts as an internal paramedic. If the heart enters a lethal rhythm like ventricular fibrillation, the ICD delivers a life saving shock to reset the heart. NICE guidelines provide strict frameworks on which device is most suitable based on the patient’s specific ECG readings and symptom severity. 

• CRT P: A biventricular pacemaker used primarily for resynchronisation. 

• CRT D: A device that provides both resynchronisation and defibrillation (shock) therapy. 

• Subcutaneous ICD (S ICD): A newer type of ICD where the leads are placed under the skin rather than inside the heart. 

• Biventricular Pacing: The process of pacing both lower chambers to improve output. 

Causes of heart failure leading to devices 

The most frequent cause of heart failure requiring device therapy in the UK is ischaemic heart disease. This occurs when a previous heart attack has left the heart muscle scarred. This scar tissue cannot contract and, more importantly, it cannot conduct electricity properly, leading to the dyssynchrony and rhythm problems mentioned earlier. 

Other causes include dilated cardiomyopathy, where the heart becomes enlarged and stretched, and valvular heart disease, where long term strain from a leaky or stiff valve weakens the muscle. In some cases, heart failure is caused by long term high blood pressure or viral infections (myocarditis) that damage the heart’s electrical grid. Regardless of the cause, once the heart reaches a certain level of weakness, device therapy becomes a standard part of the treatment plan. 

• Ischaemic Cardiomyopathy: Heart muscle weakness caused by coronary artery disease. 

• Non Ischaemic Cardiomyopathy: Weakness due to genetics, infections, or high blood pressure. 

• Myocardial Infarction: A heart attack that creates non conductive scar tissue. 

• Valvular Strain: Chronic pressure on the heart chambers that leads to enlargement. 

Triggers for advancing to device therapy 

For many patients, heart failure is initially managed well with medication. However, certain triggers can indicate that tablets are no longer enough. The most common trigger is persistent breathlessness or swelling (oedema) that does not improve even when medication doses are increased. This is often a sign that the heart’s mechanics need the support of a CRT device. 

Another trigger is a fainting episode (syncope) or a near miss where the patient feels their heart racing or fluttering. These symptoms suggest that the heart’s electrical stability is compromised, making an ICD an urgent consideration. In the UK, heart failure clinics regularly monitor patients to catch these triggers early, ensuring that device therapy is offered before a major cardiac event occurs. 

• Symptom Progression: Worsening fatigue or breathlessness despite optimal medication. 

• ECG Changes: Evidence of a Left Bundle Branch Block on a heart trace. 

• Syncope: Fainting that suggests an underlying rhythm disturbance. 

• Frequent Hospitalisation: Repeated admissions for heart failure flare ups. 

Conclusion 

Heart failure can certainly lead to device therapy when medication alone is insufficient to manage symptoms or ensure safety. Devices like CRT and ICDs provide targeted solutions for the mechanical and electrical failures that occur in a weakened heart. By improving pump efficiency and protecting against sudden cardiac arrest, these therapies significantly improve both the quality of life and the long term outlook for heart failure patients in the UK. 

If you experience severe, sudden, or worsening symptoms, such as crushing chest pain, a sudden blackout, or extreme difficulty breathing that prevents you from lying flat, call 999 immediately. 

Authority Snapshot  

This article was written by Dr. Rebecca Fernandez, a UK trained physician with an MBBS and extensive experience in cardiology, internal medicine, and emergency care. Dr. Fernandez has managed critically ill heart failure patients and stabilised acute cardiac cases in hospital settings across the UK. This content follows the latest NHS and NICE guidelines to provide accurate, evidence based information on advanced heart failure treatments.